Advancement in the development of mRNA‐based vaccines for respiratory viruses
Tays Troncoso‐Bravo,Mario A. Ramírez,Ricardo A. Loaiza,Carolina Román‐Cárdenas,Georgios Papazisis,Daniel Garrido,Pablo A. González,Susan M. Bueno,Alexis M. Kalergis
DOI: https://doi.org/10.1111/imm.13844
2024-08-21
Immunology
Abstract:Acute respiratory infections are a leading cause of death in children under 5 years of age and a significant health burden for older adults. mRNA‐based vaccines work by introducing mRNA into cells, which in turn produce viral antigens. The mRNA is usually enclosed in lipid nanoparticles (LNPs) and is endocytosed by the cell. Once inside, the mRNA is released into the cytosol, translated by ribosomes into proteins. These viral proteins are displayed on the cell membrane or secreted, triggering immune cell activation and promoting antibody production and cell‐mediated immunity, which is crucial during the COVID‐19 pandemic and promising for other respiratory viruses such as SARS‐CoV‐2, Influenza, hRSV and hMPV. Acute respiratory infections are the leading cause of death and illness in children under 5 years old and represent a significant burden in older adults. Primarily caused by viruses infecting the lower respiratory tract, symptoms include cough, congestion, and low‐grade fever, potentially leading to bronchiolitis and pneumonia. Messenger ribonucleic acid (mRNA)‐based vaccines are biopharmaceutical formulations that employ mRNA molecules to induce specific immune responses, facilitating the expression of viral or bacterial antigens and promoting immunization against infectious diseases. Notably, this technology had significant relevance during the COVID‐19 pandemic, as these formulations helped to limit SARS‐CoV‐2 virus infections, hospitalizations, and deaths. Importantly, mRNA vaccines promise to be implemented as new alternatives for fighting other respiratory viruses, such as influenza, human respiratory syncytial virus, and human metapneumovirus. This review article analyzes mRNA‐based vaccines' main contributions, perspectives, challenges, and implications against respiratory viruses.
immunology